Fig. 1From: Evaluation in alcohol use disorders – insights from the nalmefene experiencePreferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram detailing the study selection process. EMA European Medicines Agency NICE National Institute for Health and Care ExcellenceBack to article page